Candriam S.C.A. Purchases 28,999 Shares of Xylem Inc. (NYSE:XYL)

Candriam S.C.A. boosted its position in Xylem Inc. (NYSE:XYL) by 10.5% during the second quarter, HoldingsChannel.com reports. The fund owned 304,162 shares of the industrial products company’s stock after buying an additional 28,999 shares during the quarter. Candriam S.C.A.’s holdings in Xylem were worth $41,252,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. EverSource Wealth Advisors LLC increased its stake in shares of Xylem by 68.8% in the first quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after buying an additional 77 shares during the period. Blue Trust Inc. grew its position in shares of Xylem by 1,185.7% during the 2nd quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock valued at $35,000 after acquiring an additional 249 shares during the period. FinTrust Capital Advisors LLC raised its stake in shares of Xylem by 170.9% in the first quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after buying an additional 200 shares during the period. Hazlett Burt & Watson Inc. boosted its position in Xylem by 184.9% during the first quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after purchasing an additional 220 shares during the period. Finally, UMB Bank n.a. boosted its holdings in Xylem by 96.9% in the 2nd quarter. UMB Bank n.a. now owns 382 shares of the industrial products company’s stock worth $52,000 after buying an additional 188 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Price Performance

NYSE XYL opened at $126.81 on Friday. Xylem Inc. has a 52-week low of $87.59 and a 52-week high of $146.08. The firm’s 50 day moving average price is $134.13 and its 200-day moving average price is $133.70. The company has a market cap of $30.80 billion, a PE ratio of 45.13, a P/E/G ratio of 2.27 and a beta of 1.04. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.85.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, July 30th. The industrial products company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. The company had revenue of $2.17 billion during the quarter, compared to analysts’ expectations of $2.14 billion. Xylem had a return on equity of 9.48% and a net margin of 9.11%. The firm’s revenue was up 26.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.98 EPS. Sell-side analysts forecast that Xylem Inc. will post 4.26 EPS for the current fiscal year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th will be given a dividend of $0.36 per share. The ex-dividend date of this dividend is Thursday, August 29th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.14%. Xylem’s dividend payout ratio (DPR) is 51.25%.

Insider Activity

In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the transaction, the chief accounting officer now directly owns 3,536 shares in the company, valued at $490,195.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. UBS Group began coverage on shares of Xylem in a report on Tuesday, August 13th. They set a “buy” rating and a $165.00 target price on the stock. Oppenheimer lifted their price target on shares of Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. Royal Bank of Canada raised their price target on Xylem from $160.00 to $163.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 31st. Robert W. Baird boosted their price objective on shares of Xylem from $155.00 to $170.00 and gave the company an “outperform” rating in a research report on Wednesday, July 31st. Finally, TD Cowen reaffirmed a “hold” rating and issued a $138.00 target price on shares of Xylem in a research report on Tuesday. Five research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and a consensus target price of $147.54.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.